Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.71M | 7.59M | 4.08M | 3.87M | 6.79M |
| Total Receivables | 335.50K | 330.20K | 247.10K | 234.50K | 356.50K |
| Inventory | 1.33M | 1.31M | 971.50K | 921.80K | 884.00K |
| Prepaid Expenses | 299.80K | 295.10K | 206.80K | 196.20K | 331.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.60K | 3.60K | -- | -- | 110.50K |
| Total Current Assets | 9.67M | 9.52M | 5.51M | 5.23M | 8.47M |
|
|
|||||
| Total Current Assets | 9.67M | 9.52M | 5.51M | 5.23M | 8.47M |
| Net Property, Plant & Equipment | 776.70K | 764.60K | 887.90K | 842.50K | 414.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.70K | 38.10K | 26.40K | 25.00K | 25.70K |
| Total Assets | 10.49M | 10.32M | 6.42M | 6.09M | 8.91M |
|
|
|||||
| Total Accounts Payable | 755.60K | 743.80K | 1.02M | 967.80K | 1.10M |
| Total Accrued Expenses | 6.79M | 6.68M | 4.43M | 4.20M | 2.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 227.60K | 224.00K | 224.40K | 212.90K | 116.80K |
| Total Finance Division Other Current Liabilities | 100.60K | 99.10K | 35.20K | 33.40K | -- |
| Total Other Current Liabilities | 100.60K | 99.10K | 35.20K | 33.40K | -- |
| Total Current Liabilities | 7.87M | 7.75M | 5.71M | 5.42M | 4.13M |
|
|
|||||
| Total Current Liabilities | 7.87M | 7.75M | 5.71M | 5.42M | 4.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 73.70K | 72.50K | 182.60K | 173.20K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.95M | 7.82M | 5.89M | 5.59M | 4.13M |
|
|
|||||
| Common Stock & APIC | 217.87M | 214.46M | 204.92M | 194.44M | 189.82M |
| Retained Earnings | -229.70M | -226.11M | -218.49M | -207.32M | -198.38M |
| Treasury Stock & Other | 14.38M | 14.15M | 14.11M | 13.38M | 13.33M |
| Total Common Equity | 2.54M | 2.50M | 532.30K | 505.10K | 4.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.54M | 2.50M | 532.30K | 505.10K | 4.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.54M | 2.50M | 532.30K | 505.10K | 4.78M |
|
|
|||||